Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months.

Tuck-in acquisitions are a major part of the big medtech companies' strategies, especially at the likes of Medtronic and ...

The U.S. Food and Drug Administration says Medtronic's diabetes business is back in compliance. The agency issued a warning letter in December 2021 that detailed concerns about how Medtronic handled ...

Medtronic (NYSE:MDT) strengthens its healthcare offerings. Key sectors of Medtronic show growth. S&P 500 futures reflects ...

GALWAY, Ireland, July 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the ...

Mike Mensinger, vice president of engineering at Medtronic Diabetes, talks about how the company’s products and services help people manage diabetes to improve their lives. Medtronic is a medical ...

Medtronic, a global healthcare technology company, announced that MiniMed is the name for the planned new diabetes company following the intended separation. The name honors the company's roots, ...

Health tech company Medtronic is acquiring insulin patch pump company EOFlow for $738 million, the company announced Thursday. The acquisition is meant to bolster Medtronic’s diabetes offerings and ...

The U.S. Food and Drug Administration issued a warning letter to Medtronic for issues related to its diabetes business, the company said Wednesday. Medtronic received the letter last week that raised ...

Medtronic is the world’s largest pure-play medical device company. It is a dividend aristocrat, conservatively financed and well diversified. It seems like a great long-term investment. The company ...